Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SanBio Co ( (JP:4592) ) has issued an update.
SanBio Co., Ltd. has announced the determination of issue price and other details for its new shares through an international offering, aiming to raise approximately 14,202 million yen. The funds will be used primarily for clinical trials and infrastructure development for its AKUUGO® and SB623 programs, enhancing its market position in Japan and the U.S.
The most recent analyst rating on (JP:4592) stock is a Sell with a Yen1010.00 price target. To see the full list of analyst forecasts on SanBio Co stock, see the JP:4592 Stock Forecast page.
More about SanBio Co
SanBio Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of regenerative cell medicines. The company is known for its innovative therapies targeting neurological conditions, with a market focus on Japan and the United States.
Average Trading Volume: 2,779,301
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen204.9B
Find detailed analytics on 4592 stock on TipRanks’ Stock Analysis page.